Intricate technical design of the Sniper Balloon Occlusion Microcatheter allows for easy navigation through small complex vascular structures providing enhanced reach to distal target sites.

This third iteration of the innovative device delivers significant enhancements, including an extended shelf life, improved ease of use, and streamlined preparation, directly addressing critical feedback from physician users.

Designing Performance. Delivering Precision.

Sniper Product Family

Product Number Working Length Dead Space Volume Tip Outer Diameter Inner Diameter Balloon Diameter Guidewire Injection Pressure
SBC0629-STR-110 110 cm 0.32 ml Straight tip

Proximal 2.9F/0.038"

Distal 2.2F/0.029"

 0.020"/0.5 mm Up to 6 mm 0.014" or 0.016" Up to 900 psi
SBC0629-STR-130 130 cm 0.36 ml
SBC0629-STR-150 150 cm 0.41 ml
SBC0629-STR-165 165 cm 0.45 ml
SBC0629-KTP-110 110 cm 0.32 ml K-tip
SBC0629-KTP-130 130 cm 0.36 ml
SBC0629-KTP-150 150 cm 0.41 ml
Product Number Working Length Dead Space Volume Tip Outer Diameter
SBC0629-STR-110 110 cm 0.32 ml Straight tip

Proximal 2.9F/0.038"

Distal 2.2F/0.029"
SBC0629-STR-130 130 cm 0.36 ml
SBC0629-STR-150 150 cm 0.41 ml
SBC0629-KTP-110 110 cm 0.32 ml K-tip
SBC0629-KTP-130 130 cm 0.36 ml
SBC0629-KTP-150 150 cm 0.41 ml
Inner Diameter Balloon Diameter Guidewire Injection Pressure
0.020"/0.5 mm Up to 6 mm 0.014" or 0.016" Up to 900 psi
Product Number Working Length Dead Space Volume
SBC0629-STR-110 110 cm 0.32 ml
SBC0629-STR-130 130 cm 0.36 ml
SBC0629-STR-150 150 cm 0.41 ml
SBC0629-KTP-110 110 cm 0.32 ml
SBC0629-KTP-130 130 cm 0.36 ml
SBC0629-KTP-150 150 cm 0.41 ml
Tip Outer Diameter Inner Diameter
Straight tip

Proximal 2.9F/0.038"

Distal 2.2F/0.029"

 0.020"/0.5 mm
K-tip
Balloon Diameter Guidewire Injection Pressure
Up to 6 mm 0.014" or 0.016" Up to 900 psi

Examples of Cases & Studies where Sniper was Used

The examples below are shared for informational purposes only. The Sniper device has                                                                                                                                                               not been evaluated or cleared by the FDA for the indications reflected in these examples.
    • Therapeutic agent delivery and healthy tissue protection                                                                                                                                                         Reference 1, 2, 3, 4, 5
    • Transarterial Embolization (TAE)                                                                                                                                                                                                             (PAE is an example of TAE)                                                                                                                                                                                                       Reference 6, 7, 8
    • Transarterial Chemoembolization (TACE)                                                                                                                                                                                 Reference 9, 10, 11, 12, 13
    • Radioembolization (Y-90)                                                                                                                                                                                                         Reference 14, 15, 16, 17
    • Arteriovenous Malformation (AVM)                                                                                                                                                                                           Reference 18
    • Prostate Artery Embolization (PAE)                                                                                                                                                                                         Reference 19, 20, 21, 22
    • Renal Angiomyolipoma (AML)                                                                                                                                                                                                 Reference 23, 24
    • Glue (n-BCA)                                                                                                                                                                                                                           Reference 27
    • Spherical Particles                                                                                                                                                                                                                   Reference 28, 29, 30, 31
    • Dimethyl Sulfoxide (DMSO) & Onyx                                                                                                                                                                                         Reference 32

Designed for arterial embolization procedures such as:

  • Transarterial Embolization (TAE)
  • Transarterial Chemoembolization (TACE)
  • Radioembolization (Y-90)
  • Arteriovenous Malformation (AVM)
  • Prostate Artery Embolization (PAE)
  • Gastrointestinal Bleeds
  • Renal Angiomyolipoma (AML)
  • Uterine Fibroid Embolization (UFE)

References

  1. Mabley H, Cornman-Homonoff, Madoff D. Balloon-assisted radioembolization via the proper hepatic artery to treat a left liver hepatocellular carcinoma and portal vein tumor thrombus with an inaccessible left hepatic artery: a case report. Clinical Imaging (2022) 82:244-250. (Sniper Balloon Microcatheter)
  2. Young LB, Kolber M, King MJ, Ranade M, Bishay VL, Patel RS, Nowakowski FS, Fischman AM, Lookstein RA, Kim E. Intrahepatic flow diversion prior to segmental yttrium-90 radioembolization for challenging tumor vasculature. Journal of Interventional Medicine (2022) 5:79-83. (Sniper Balloon Microcatheter)
  3. Tanaka M, Uppot R, Daye D, Liu R and Wehrenberg‑Klee E. The double‑balloon technique: a safe and effective adjunctive technique in patients undergoing arterial therapy for hepatic malignancies with vascular supply not amenable to selective administration. CVIR (2023) 6:3. (Sniper Balloon Microcatheter)
  4. Core JM, Frey GT, Sharma A, Bussone ST, Legout JD, McKinney JM, Lewis AR, Ritchie C, Devcic Zlatko, Paz-Fumagalli R, Toskich BB. Increasing Yttrium-90 dose conformality using proximal Radioembolization enabled by distal angiosomal truncation for the treatment of hepatic malignancy. J Vasc Interv Radiol 2020; 31:934–942. (Sniper Balloon Microcatheter)
  5. Rose S, Halstead G, Narsinh K. Pressure-Directed Embolization of Hepatic Arteries in a Porcine Model Using a Temporary Occlusion Balloon Microcatheter: Proof of Concept. Cardiovasc Intervent Radiol (2017) 40: 1769. (Sniper Balloon Microcatheter)
  6. Bilhim T, Costa NV, Torres D, Pisco J, Carmo S, Oliveria A. Randomized Clinical trial of balloon occlusion versus conventional microcatheter prostatic artery embolization for benign prostatic hyperplasia. JVIR (2019) 30 1798-1806. (Sniper Balloon Microcatheter)
  7. Isaacson A, Hartman T, Bagla S, Burke C. Initial Experience with Balloon-Occlusion Prostatic Artery Embolization. J Vasc Interv Radiol (2018) 29: 85-89. (Sniper Balloon Microcatheter)
  8. Keasler E, Isaacson A. Changes in Prostatic Artery Angiography with Balloon Occlusion. J Vasc Interv Radiol (2017) 28:1276-1278. (Sniper Balloon Microcatheter)
  9. Goldman D, Singh M, Patel R, Fischman A et al. Balloon-Occluded Transarterial Chemoembolization (B-TACE) for the Treatment of Hepatocellular Carcinoma: A Single Center U.S. Preliminary Experience. J Vasc Interv Radiol (2019) 30:342–346. (Sniper Balloon Microcatheter)
  10. Lee KS, Madoff DC. Segmental balloon-occluded transarterial chemoembolization of hepatocellular carcimoma. SIR 2021, Abstract & Poster. (Sniper Balloon Microcatheter)
  11. Stein S, Madoff D. Balloon-assisted transarterial chemoembolic (B-TACE) segmentectomy: an alternative strategy in the treatment of hypovascular oligometastatic liver metastases. J Vasc Interv Radiol (2019). (Sniper Balloon Microcatheter)
  12. Stein S, Madoff D. Low Pressure-Directed Balloon-Assisted Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Angiographic Proof of Concept. J Vasc Interv Radiol (2019). (Sniper Balloon Microcatheter)
  13. Kouri B. Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy. Techniques in Vascular & Interventional Radiology (2018) 21:205-222. (Sniper Balloon Microcatheter)
  14. Young LB, Kolber M, King MJ, Ranade M, Bishay VL, Patel RS, Nowakowski FS, Fischman AM, Lookstein RA, Kim E. Intrahepatic flow diversion prior to segmental yttrium-90 radioembolization for challenging tumor vasculature. Journal of Interventional Medicine (2022) 5:79-83. (Sniper Balloon Microcatheter)
  15. Tanaka M, Uppot R, Daye D, Liu R and Wehrenberg‑Klee E. The double‑balloon technique: a safe and effective adjunctive technique in patients undergoing arterial therapy for hepatic malignancies with vascular supply not amenable to selective administration. CVIR (2023) 6:3. (Sniper Balloon Microcatheter)
  16. Core JM, Frey GT, Sharma A, Bussone ST, Legout JD, McKinney JM, Lewis AR, Ritchie C, Devcic Zlatko, Paz-Fumagalli R, Toskich BB. Increasing Yttrium-90 dose conformality using proximal Radioembolization enabled by distal angiosomal truncation for the treatment of hepatic malignancy. J Vasc Interv Radiol 2020; 31:934–942. (Sniper Balloon Microcatheter)
  17. Mabley H, Cornman-Homonoff, Madoff D. Balloon-assisted radioembolization via the proper hepatic artery to treat a left liver hepatocellular carcinoma and portal vein tumor thrombus with an inaccessible left hepatic artery: a case report. Clinical Imaging (2022) 82:244-250. (Sniper Balloon Microcatheter)
  18. Rose S, Berman Z, Fischman A, Young L, Flanagan S, Katz M, Diiulio M, Kuban J, Golzarian J. Inline balloon occlusion-assisted delivery of ethylene vinyl alcohol copolymer for peripheral arterial applications: a multicenter case series. JVIR (2020) https://doi.org/10.1016/j.jvir.2020.01.005 (Sniper Balloon Microcatheter)
  19. Lee KS, Madoff DC. Segmental balloon-occluded transarterial chemoembolization of hepatocellular carcimoma. SIR 2021, Abstract & Poster. (Sniper Balloon Microcatheter)
  20. Goldman D, Singh M, Patel R, Fischman A et al. Balloon-Occluded Transarterial Chemoembolization (B-TACE) for the Treatment of Hepatocellular Carcinoma: A Single Center U.S. Preliminary Experience. J Vasc Interv Radiol (2019) 30:342–346. (Sniper Balloon Microcatheter)
  21. Isaacson A, Hartman T, Bagla S, Burke C. Initial Experience with Balloon-Occlusion Prostatic Artery Embolization. J Vasc Interv Radiol (2018) 29: 85-89. (Sniper Balloon Microcatheter)
  22. Bilhim T, Costa NV, Torres D, Pisco J, Carmo S, Oliveria A. Randomized Clinical trial of balloon occlusion versus conventional microcatheter prostatic artery embolization for benign prostatic hyperplasia. JVIR (2019) 30 1798-1806. (Sniper Balloon Microcatheter)
  23. Keasler E, Isaacson A. Changes in Prostatic Artery Angiography with Balloon Occlusion. J Vasc Interv Radiol (2017) 28:1276-1278. (Sniper Balloon Microcatheter)
  24. Kolyvas P, Aljundi M, Sivananthan G. Treatment of hepatocellular carcinoma with arterioportal shunting using balloon-assisted transarterial yttrium-90 radiation segmentectomy: A case report. American Journal of Interventional Radiology. DOI 10.25259/AJIR_17_2023. – Sniper
  25. Shah K, Acharya V, Bhatia Shivank. Utility of the Sniper balloon occlusion microcatheter in prostate areterty embolization: Early institutional experience. 2021 SIR Abstract. (Sniper Balloon Microcatheter)
  26. Rose S, Berman Z, Fischman A, Young L, Flanagan S, Katz M, Diiulio M, Kuban J, Golzarian J. Inline balloon occlusion-assisted delivery of ethylene vinyl alcohol copolymer for peripheral arterial applications: a multicenter case series. JVIR (2020) https://doi.org/10.1016/j.jvir.2020.01.005 (Sniper Balloon Microcatheter)
  27. Goldman D, Singh M, Patel R, Fischman A et al. Balloon-Occluded Transarterial Chemoembolization (B-TACE) for the Treatment of Hepatocellular Carcinoma: A Single Center U.S. Preliminary Experience. J Vasc Interv Radiol (2019) 30:342–346. (Sniper Balloon Microcatheter)
  28. Isaacson A, Hartman T, Bagla S, Burke C. Initial Experience with Balloon-Occlusion Prostatic Artery Embolization. J Vasc Interv Radiol (2018) 29: 85-89. (Sniper Balloon Microcatheter)
  29. Bilhim T, Costa NV, Torres D, Pisco J, Carmo S, Oliveria A. Randomized Clinical trial of balloon occlusion versus conventional microcatheter prostatic artery embolization for benign prostatic hyperplasia. JVIR (2019) 30 1798-1806. (Sniper Balloon Microcatheter)
  30. Keasler E, Isaacson A. Changes in Prostatic Artery Angiography with Balloon Occlusion. J Vasc Interv Radiol (2017) 28:1276-1278. (Sniper Balloon Microcatheter)
  31. Bamshad D, Sanghvi J, Galla N, Geffner A, Menon K, Bishay V, Fischman A et al. Early Outcomes of Prostatic Artery embolization using n-butyl cyanoacrylate liquid embolic agent: A safety and feasibility study. J Vasc Interv Radiol 2024; 35:1855–1861. (Sniper Balloon Microcatheter)
  32. Rose S, Berman Z, Fischman A, Young L, Flanagan S, Katz M, Diiulio M, Kuban J, Golzarian J. Inline balloon occlusion-assisted delivery of ethylene vinyl alcohol copolymer for peripheral arterial applications: a multicenter case series. JVIR (2020) https://doi.org/10.1016/j.jvir.2020.01.005 (Sniper Balloon Microcatheter)
  33. Irie T, Kuramochi M, Takahashi N. Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodules during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure. Cariovasc Intervent Radiol (2013) 36: 706-713. (Occlusafe Balloon Microcatheter, Terumo Corporation)
  34. Maruyama M, Yoshizako T, Nakamura T, et al. Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (BTACE) for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. (2016) 39: 359-366. (Occlusafe Balloon Microcatheter, Terumo Corporation)
  35. Lucatelli P, De Rubeis G, Trobiani C, Ungania S, Rocco, B, De Gyurgyokai S, Masi M, Pecorella I, Cappelli F, Lai Q, Catalano C, Vallati G. In Vivo comparison of micro-balloon interventions (MBI) Advantage: A retrospective cohort study of DEB-TACE versus b-TACE and of SIRT versus b-SIRT. Cardiovasc Intervent Radiol, (2021) On-Line. https://doi.org/10.1007/s00270-021-03035-5. (Occlusafe Balloon Microcatheter, Terumo Corporation)
  36. Golfieri R, Bezzi M, Verset G, Fucilli F, Mosconi C, Cappelli A. Cardio Intervent Radiol (2021) https://doi.org/10.1007/s00270-021-02805-5. (Occlusafe Balloon Microcatheter, Terumo Corporation)
  37. Irie T, Kuramochi M, Kamoshida T, Takahashi N. Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: retrospective comparison with conventional super-selective TACE. Hepatology Research (2016) 46:209-214. (Occlusafe Balloon Microcatheter, Terumo Corporation)
  38. Arai H, Abe T, Takayama H, et al. Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma. Hepatology Research (2015) 45: 663-666. (Occlusafe Balloon Microcatheter, Terumo Corporation)
  39. Lucatelli P, De Rubeis G, Trobiani C, Ungania S, Rocco, B, De Gyurgyokai S, Masi M, Pecorella I, Cappelli F, Lai Q, Catalano C, Vallati G. In Vivo comparison of micro-balloon interventions (MBI) Advantage: A retrospective cohort study of DEB-TACE versus b-TACE and of SIRT versus b-SIRT Cardiovasc Intervent Radiol, (2021) On-Line. https://doi.org/10.1007/s00270-021-03035-5. (Occlusafe Balloon Microcatheter, Terumo Corporation)
  40. Ogawa M, Takayasu K, Hirayama M, et al. Efficacy of a microballoon catheter in transarterial chemoembolization using miriplatin, a lipophilic anticancer drug: short-term results. Hepatology Research (2016) 46: E60-69. (Occlusafe Balloon Microcatheter, Terumo Corporation)
  41. Shirono T, Iwamoto H, Niizeki T, Shigeo S, Kajiwara A, Suzuki H, Kamachi N, Noda Y, Shusuke O, Masahito N, Kuromatsu R, Murotani K, Koga H, Torimura T. Durable complete response is achieved by balloon occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatology Communications. (2022) 6:2594-2604. (Occlusafe Balloon Microcatheter, Terumo Corporation)
Contact Us Today!

 

530 Lakeside Dr. #150, Sunnyvale, CA 94085
+1-408-990-2949 | Contact Us

Sign Up for Updates